The fundamental concept, that interindividual differences among prostate glands can explain varying responses to treatment, remains intact. A simple test to pinpoint those differences remains the challenge.
Marks
L S
LS
D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011379:Prognosis; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D018120:Finasteride; D017430:Prostate-Specific Antigen